Tata Chemicals Limited
Tata Chemicals Limited (TATACHEM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
tatachemicals.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹633.95
Market cap
16,085 Cr
P/B
0.73
Dividend yield
1.7%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,998 Cr | 3,730 Cr | 3,475 Cr | 3,789 Cr | 3,999 Cr | 3,590 Cr | 3,509 Cr | 3,719 Cr | 3,877 Cr | 3,550 Cr | 3,438 Cr | 4,255 Cr |
| Operating expenses (approx.) | 3,179 Cr | 3,188 Cr | 3,032 Cr | 3,215 Cr | 3,381 Cr | 3,156 Cr | 3,182 Cr | 3,070 Cr | 3,340 Cr | 3,205 Cr | 3,164 Cr | 3,700 Cr |
| EBITDA | 819 Cr | 542 Cr | 443 Cr | 574 Cr | 618 Cr | 434 Cr | 327 Cr | 649 Cr | 537 Cr | 345 Cr | 274 Cr | 555 Cr |
| OPM % | 20.5% | 14.5% | 12.7% | 15.1% | 15.5% | 12.1% | 9.3% | 17.5% | 13.9% | 9.7% | 8.0% | 13.0% |
| Other income | 85 Cr | 38 Cr | 114 Cr | 47 Cr | 108 Cr | 28 Cr | 42 Cr | 96 Cr | 138 Cr | 38 Cr | 44 Cr | 56 Cr |
| Interest | 145 Cr | 132 Cr | 130 Cr | 133 Cr | 145 Cr | 148 Cr | 137 Cr | 147 Cr | 144 Cr | 146 Cr | 153 Cr | 148 Cr |
| Depreciation | 234 Cr | 246 Cr | 271 Cr | 273 Cr | 277 Cr | 280 Cr | 293 Cr | 280 Cr | 285 Cr | 293 Cr | 343 Cr | 336 Cr |
| Profit before tax | 615 Cr | 262 Cr | -819 Cr | 235 Cr | 348 Cr | -4 Cr | -89 Cr | 360 Cr | 236 Cr | -73 Cr | -1,982 Cr | 110 Cr |
| Tax % | 19.5% | 26.0% | -2.7% | 40.0% | 23.3% | -425.0% | 28.1% | 12.2% | 34.7% | 5.5% | -6.8% | 45.5% |
| Net profit | 495 Cr | 194 Cr | -841 Cr | 190 Cr | 267 Cr | -21 Cr | -49 Cr | 316 Cr | 154 Cr | -69 Cr | -2,116 Cr | 60 Cr |
| EPS (₹) | ₹16.80 | ₹6.20 | ₹-33.36 | ₹5.89 | ₹7.61 | ₹-2.08 | ₹-2.19 | ₹9.89 | ₹3.02 | ₹3.65 | ₹-83.68 | ₹-0.67 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,296 Cr | 10,357 Cr | 10,200 Cr | 12,622 Cr | 16,789 Cr | 15,421 Cr | 14,887 Cr | 14,584 Cr | Sign in for TTM |
| Operating expenses (approx.) | 9,201 Cr | 8,408 Cr | 8,699 Cr | 10,317 Cr | 12,967 Cr | 12,574 Cr | 12,934 Cr | 12,779 Cr | Sign in for TTM |
| EBITDA | 2,095 Cr | 1,949 Cr | 1,501 Cr | 2,305 Cr | 3,822 Cr | 2,847 Cr | 1,953 Cr | 1,805 Cr | Sign in for TTM |
| OPM % | 18.5% | 18.8% | 14.7% | 18.3% | 22.8% | 18.5% | 13.1% | 12.4% | Sign in for TTM |
| Other income | 412 Cr | 311 Cr | 234 Cr | 256 Cr | 218 Cr | 286 Cr | 225 Cr | 316 Cr | Sign in for TTM |
| Interest | 363 Cr | 342 Cr | 367 Cr | 303 Cr | 406 Cr | 530 Cr | 563 Cr | 590 Cr | Sign in for TTM |
| Depreciation | 571 Cr | 666 Cr | 759 Cr | 806 Cr | 892 Cr | 980 Cr | 1,123 Cr | 1,201 Cr | Sign in for TTM |
| Profit before tax | 1,631 Cr | 7,411 Cr | 634 Cr | 1,459 Cr | 2,722 Cr | 816 Cr | 414 Cr | -1,459 Cr | Sign in for TTM |
| Tax % | 21.3% | 3.0% | 31.2% | 18.3% | 10.6% | 46.7% | 40.3% | -17.5% | Sign in for TTM |
| Net profit | 1,387 Cr | 7,228 Cr | 436 Cr | 1,405 Cr | 2,434 Cr | 435 Cr | 387 Cr | -1,715 Cr | Sign in for TTM |
| EPS (₹) | ₹45.38 | ₹275.02 | ₹10.06 | ₹49.37 | ₹90.95 | ₹10.52 | ₹9.23 | ₹-74.42 | Sign in for TTM |
| Dividend payout % | — | — | — | 18.2% | 13.1% | 102.8% | 98.7% | — | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 255 Cr | 255 Cr | 255 Cr | 255 Cr | 255 Cr | 255 Cr | 255 Cr | 255 Cr |
| Reserves | 15,001 Cr | 13,407 Cr | 14,888 Cr | 18,903 Cr | 20,387 Cr | 22,859 Cr | 22,246 Cr | 21,920 Cr |
| Borrowings | — | — | — | — | 6,296 Cr | 5,563 Cr | 7,072 Cr | 8,001 Cr |
| Other liabilities | 11,649 Cr | 14,091 Cr | 13,195 Cr | 14,686 Cr | 8,146 Cr | 8,079 Cr | 8,207 Cr | 8,855 Cr |
| Total liabilities | 26,905 Cr | 27,752 Cr | 28,337 Cr | 33,843 Cr | 35,084 Cr | 36,756 Cr | 37,780 Cr | 39,031 Cr |
| Fixed assets (net) | — | — | — | — | 6,367 Cr | 6,786 Cr | 8,073 Cr | 9,920 Cr |
| CWIP | — | — | — | — | 2,351 Cr | 2,165 Cr | 1,879 Cr | 1,014 Cr |
| Investments | — | — | — | — | 7,500 Cr | 9,791 Cr | 9,194 Cr | 9,916 Cr |
| Loans & advances | — | — | — | — | 325 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | — | — | — | — | 2,532 Cr | 2,524 Cr | 2,558 Cr | 3,082 Cr |
| Trade receivables | — | — | — | — | 2,627 Cr | 1,900 Cr | 1,900 Cr | 2,088 Cr |
| Cash & bank | — | — | — | — | 508 Cr | 425 Cr | 548 Cr | 381 Cr |
| Other assets | 26,905 Cr | 27,752 Cr | 28,337 Cr | 33,843 Cr | 12,874 Cr | 13,165 Cr | 13,628 Cr | 12,630 Cr |
| Total assets | 26,905 Cr | 27,752 Cr | 28,337 Cr | 33,843 Cr | 35,084 Cr | 36,756 Cr | 37,780 Cr | 39,031 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 1,644 Cr | 2,971 Cr | 3,016 Cr | 1,761 Cr | 1,269 Cr |
| Cash from investing | — | — | — | -836 Cr | -1,186 Cr | -610 Cr | -1,681 Cr | -809 Cr |
| Cash from financing | — | — | — | -755 Cr | -2,076 Cr | -2,494 Cr | 29 Cr | -670 Cr |
| Net cash flow | — | — | — | 72 Cr | -254 Cr | -83 Cr | 123 Cr | -167 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 368 Cr | 1,393 Cr | 1,182 Cr | -244 Cr | 64 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 13.1% | 56.8% | 6.6% | 9.2% | 11.6% | 4.7% | 3.3% | -2.9% |
| ROE % | 7.6% | 51.3% | 1.7% | 6.6% | 11.2% | 1.2% | 1.0% | -8.6% |
| Debtor days | — | — | — | — | 57 | 45 | 46 | 52 |
| Inventory days | — | — | — | — | 313 | 340 | 364 | 379 |
| Days payable | — | — | — | — | 321 | 319 | 357 | 314 |
| Cash conversion cycle | — | — | — | — | 49 | 66 | 53 | 117 |
| Debt / equity | — | — | — | — | 0.32 | 0.25 | 0.33 | 0.38 |
| Current ratio | — | — | — | — | 1.66 | 1.05 | 1.09 | 1.07 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 | 1.80 | 3.34 | 4.22 |
Compare with peers
Loading peers…